Showing results (2071-2080 of 2,138) with videos related to
Sort By:
Pageof 214
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.International Journal for Parasitology|July 3, 2010
Multi-centre testing and validation of current protocols for the identification of Gyrodactylus salaris (Monogenea)A P Shinn, C Collins, A García-Vásquez, et al.Cancer Discovery|December 19, 2013
Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemiaRongqing Pan, Leah J Hogdal, Juliana M Benito, et al.Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.Blood|October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 studyEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.Blood Advances|October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapseH Moses Murdock, Haesook T Kim, Katie Maurer, et al.Leukemia|July 14, 2015
Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemiaH Wu, C Hu, A Wang, et al.The New England Journal of Medicine|December 8, 2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaBrian J Druker, François Guilhot, Stephen G O'Brien, et al.Blood Advances|July 5, 2022
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AMLKarilyn T Larkin, Deedra Nicolet, Benjamin J Kelly, et al.Pageof 214